Clinical Trials Logo

Periportal Fibrosis clinical trials

View clinical trials related to Periportal Fibrosis.

Filter by:
  • None
  • Page 1

NCT ID: NCT01260012 Recruiting - Oxidative Stress Clinical Trials

Antioxidant Supplements in the Reversal of Schistosomal Peri-portal Fibrosis

Start date: January 2010
Phase: N/A
Study type: Interventional

Liver fibrosis is the most serious complication of schistosomiasis mansoni. However only limited proportion of subjects with infection develop this pathology and there is limited knowledge on risk factors for the differential morbidity patterns observed in endemic communities. Our preliminary cross-sectional study indicated that serum levels of antioxidants may be related with the development of fibrosis. The present project is a randomised double blinded placebo controlled prospective study investigating the role of food based antioxidant supplements on the outcome of anti-schistosomal chemotherapy with regards to the extent of fibrosis reversal.